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lar organisms for disposal of cells that are no longer needed or potentially detrimental. Given the crucial role of
apoptosis in physiology, deregulation of apoptoticmachinery is associatedwith various diseases aswell as abnor-
malities in development. Acquired resistance to apoptosis represents the common feature of most and perhaps
all types of cancer. Therefore, repairing and reactivating apoptosis represents a promising strategy toﬁght cancer.
Accumulated evidence identiﬁes ion channels as essential regulators of apoptosis. However, the contribution of
speciﬁc ion channels to apoptosis varies greatly depending on cell type, ion channel type and intracellular local-
ization, pathology aswell as intracellular signaling pathways involved. Herewe discuss the involvement ofmajor
types of ion channels in apoptosis regulation. This article is part of a Special Issue entitled: Membrane channels
and transporters in cancers.
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Apoptosis, a type of genetically controlled or programmed cell death,
is a fundamental cellularmechanismutilized bymulticellular organisms
for disposal of cells that are no longer needed or potentially detrimental
[1]. Apoptosis is essential for normal tissue homeostasis and it is in-
volved in cell turnover in many tissues. Further, apoptosis plays anne channels and transporters in
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. Prevarskaya).important role in embryonic development, morphogenesis and shaping
organisms [2]. Indeed, during embryonic development neuronal apo-
ptosis sculpts the developing brain [3] whereas interdigital cell death
contributes to digit individualization [4]. The role of apoptosis in termi-
nation of immune responses has also been reported [5,6]. Given the cru-
cial role of apoptosis in physiology, it is not surprising that deregulation
of apoptotic machinery is associated with various diseases as well as
abnormalities in development. A number of pathological conditions, in-
cluding cancer, viral infections and autoimmune diseases are character-
ized by apoptosis impairment, while other diseases, such as AIDS
(acquired immunodeﬁciency syndrome), osteoporosis and neurode-
generative diseases involve increased apoptotic rate [7].
Accumulated evidence suggests that apoptosis plays an integral part
in tumor development and progression [8]. Impairment in apoptosis
2533A. Kondratskyi et al. / Biochimica et Biophysica Acta 1848 (2015) 2532–2546breaks the balance between cell death and cell proliferation, leads to ac-
cumulation of “undead” cells and therefore supports cancerogenesis.
Given that acquired resistance to apoptosis represents the common fea-
ture of most and perhaps all types of cancer, “evading apoptosis” has
been deﬁned by Hanahan and Weinberg as one of cancer hallmarks
[9]. Resistance to apoptosis has been also implicated in moderate efﬁ-
ciency or failure of a number of anticancer treatments. Thus, targeting
apoptosis represents a promising strategy to ﬁght cancer [10,11].
Numerous studies suggest that by providing the inﬂux/efﬂux of es-
sential signaling ions, regulating cytoplasmic/intraorganellar ion con-
centrations, controlling cell volume, and maintaining membrane
potential, ion channels are essential regulators of a number of funda-
mental cellular processes, including apoptosis [12–14].Malignant trans-
formation of cells, which is facilitated by apoptosis impairment, is often
accompanied by alterations in ion channels' expression/function.
Among these are both plasmamembrane ion channels and intracellular
ion channels, including potassium, calcium, sodium, and chloride chan-
nels, store-operated calcium channels, TRP (transient receptor poten-
tial) channels and others [15,16].
Here, we discuss the involvement of major types of ion channels in
apoptosis regulatory pathways and the possible use of these channels
in cancer treatment.
2. The apoptotic machinery
Apoptosis could be distinguished from other types of cell death by
characteristic biochemical and morphological features including cell
shrinkage, chromatin condensation, nuclear fragmentation, membrane
blebbing and apoptotic bodies formation [1]. These bodies are subse-
quently phagocytosed bymacrophages or neighboring cells. Important-
ly, as no cell leakage occurs during apoptosis, there is essentially no
inﬂammatory reaction associatedwith this type of cell death in contrast
to necrosis [17]. Thus, apoptosis represents a specialized tool for the
body to focally and quietly eliminate unwanted cells with minimal if
any bothering of nearby cells. It's clear that to achieve this result apopto-
sis should be tightly controlled at all stages, from initiation to ﬁnal
phagocytosis of apoptotic bodies.
The apoptotic machinery is highly complex and sophisticated, in-
volving a variety of molecular players. Depending on the mechanism
of initiation, signaling pathways that lead to apoptosis can be divided
to two core pathways: the extrinsic (death receptor) pathway and the
intrinsic (mitochondrial) pathway. However, it should be noted that de-
spite the differences in mechanisms of initiation and molecules in-
volved, these two pathways are closely interrelated [17,18]. Most of
the morphological and biochemical changes observed in apoptotic
cells are primarily caused by the activity of a family of cysteine proteases
called caspases, which normally exist in healthy cells as inactive proen-
zymes and become activated upon apoptosis initiation [19]. Most of the
known caspases have the role in apoptosis and can be divided into two
groups: initiator caspases (e.g. caspase-8, caspase-9 and caspase-10)
and effector caspases (e.g. caspase-3, caspase-6 and caspase-7). Initiator
caspases activate effector caspases, which in turn realize much of the
proteolisis and DNAses activation seen in apoptosis [19]. However, al-
though pronounced caspase activation is frequently found in apoptosis,
the cases of caspase-independent apoptosis have been reported as well
[17,20].
As it goes from its name, intrinsic or mitochondrial pathway is initi-
ated from within the cell and involves mitochondria as central regula-
tors. The intrinsic pathway is highly regulated by the interactions
between pro- and anti-apoptotic members of the B cell lymphoma 2
(BCL-2) family of proteins [21]. Stimuli that initiate this pathway in-
clude DNA damage, oxidative stress, unfolded proteins accumulation,
cytosolic calciumoverload and others. All of these stimuli induce chang-
es inmitochondrial membranes permeability either through opening of
mitochondrial permeability transition pore (MPTP) or through the
pore-forming activity of pro-apoptotic members of the BCL-2 proteinfamily, such as BCL-2-associated X protein (BAX) or BCL-2 antagonist
or killer (BAK) [21–23]. The resulting mitochondrial outer membrane
permeabilization (MOMP) causes loss ofmitochondrial transmembrane
potential (Δψm), arrest of mitochondrial ATP synthesis and release of
pro-apoptotic proteins from intermembrane space into the cytosol.
These pro-apoptotic proteins include cytochrome c (Cyt C), second
mitochondria-derived activator of caspases/direct IAP-binding protein
with low pl (SMAC/DIABLO), apoptosis-inducing factor (AIF), endonu-
clease G (EndoG), high-temperature requirement protein A2 (HTRA2/
Omi) and others [24]. Cyt C, once released into the cytoplasm, forms
apoptosome (by binding to apoptotic protease activating factor 1
(Apaf-1) and dATP) and triggers the activation of initiator caspase-9,
which in turn activates effector caspase-3 [25]. HTRA2/Omi and
SMAC/DIABLO antagonize inhibitors of apoptosis proteins (IAPs),
thereby activating caspases (Fig. 1) [26,27]. In addition, HTRA2/Omi
can induce caspase-independent apoptosis via its serine protease activ-
ity [28]. EndoG and AIF translocate to the nucleus, where they mediate
caspase-independent DNA fragmentation [29,30].
Unlike intrinsic pathway, extrinsic pathway is induced by extracellu-
lar pro-apoptotic signals that activate speciﬁc surface receptors called
death receptors (members of the tumor necrosis factor (TNF) receptor
family) which in turn trigger apoptosis via caspase-dependent pathway
[17,20,31]. Extracellular pro-apoptotic signals or ligands and their re-
spective receptors include FAS/CD95 ligand—binds to CD95,
TNFα—binds to TNFR1, TNF-related apoptosis inducing ligand
(TRAIL)—binds to TRAILR1–2, and others [31]. Binding of ligands to
death receptors initiates the formation ofmultiprotein complex dubbed
death-inducing signaling complex (DISC), resulting in activation of ini-
tiator caspase-8 [32]. Active caspase 8 directly activates caspase-3,
thereby triggering caspase-dependent apoptosis. Alternatively,
caspase-8 mediates the cleavage of Bcl2-protein family member BH3-
interacting domain death agonist (BID), resulting in a pro-apoptotic
truncated BID (tBID), inducing subsequent MOMP, release of CytC
from mitochondria and triggering caspase9-dependent apoptosis
(Fig. 1) [33,34]. Of note, apart from death receptors, another receptor
types, called dependence receptors, have been also demonstrated to
mediate extrinsic apoptosis [35].
3. Ion channels in the regulation of cell apoptosis
Ion channels are integral membrane proteins that mediate the in-
ﬂux/efﬂux of essential signaling ions into/from the cell or intracellular
organelles thereby controlling cytoplasmic/intraorganellar ion concen-
trations, membrane potential and cell volume. Numerous studies have
demonstrated the involvement of different ion channels in the regula-
tion of fundamental cellular processes, such as proliferation and apopto-
sis [12,13]. Among these channels are both plasma membrane- and
intracellular ion channels, including potassium, calcium, sodium, and
chloride channels, store-operated calcium channels, TRP (transient re-
ceptor potential) channels and others [15,16].
Further, we discuss speciﬁc roles of various ion channels in apoptosis
in cancer, categorized by ion channel families.
3.1. Calcium and calcium-permeable channels
Calcium is a ubiquitous intracellularmessenger playing a central role
inmany fundamental cellular processes such as cell proliferation, differ-
entiation, gene transcription and cell death [36]. Numerous studies indi-
cate that calcium is an important regulator of apoptosis at all stages,
from initiation to ﬁnal phagocytosis of apoptotic bodies [37,38]. Cyto-
plasmic calcium overload has been shown to promote apoptosis via dif-
ferent pathways. For example, excessive elevation of calcium in the
cytosol stimulates increase in mitochondrial calcium uptake, which in
turn can induce opening of MPTP resulting in triggering of intrinsic ap-
optotic pathway [24,39,40]. Another mechanism involves Ca2+-
dependent cysteine proteases, called calpains, which mediate cleavage
Fig. 1. Ions and ion channels in the regulation of apoptosis. Extrinsic and intrinsic apoptotic pathways are represented. Intrinsic pathway is initiated from within the cell following DNA
damage, ER stress etc. These stimuli induce changes in mitochondrial membranes permeability which causes the release of proapoptotic factors from the intermembrane space. These
pro-apoptotic proteins include cytochrome c (Cyt C), second mitochondria-derived activator of caspases/direct IAP-binding protein with low pl (SMAC/DIABLO), high-temperature re-
quirement protein A2 (HTRA2/Omi) and others. Cyt C, once released into the cytoplasm, forms apoptosome (by binding to apoptotic protease activating factor 1 (Apaf-1) and dATP)
and triggers the activation of initiator caspase-9, which in turn activates effector caspase-3. HTRA2/Omi and SMAC/DIABLO antagonize inhibitors of apoptosis proteins (IAPs), thereby
activating caspases. Extrinsic pathway is induced by extracellular pro-apoptotic signals or ligands that activate death receptors which in turn trigger apoptosis via caspase-dependent
pathway. Binding of ligands to death receptors initiates the formation of multiprotein complex dubbed death-inducing signaling complex (DISC), resulting in activation of initiator
caspase-8. Active caspase 8 directly activates caspase-3, thereby triggering caspase-dependent apoptosis. Alternatively, caspase-8 mediates the cleavage of Bcl2-protein family member
BH3-interacting domain death agonist (BID), resulting in a pro-apoptotic truncated BID (tBID), inducing subsequent MOMP, release of CytC from mitochondria and triggering
caspase9-dependent apoptosis. Major types of ion channels involved in apoptosis regulation are represented.
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well as anti-apoptotic BCL-2 and BCL-2-like protein 1 (BCL-XL)), and
promote MOMP and Cyt C release [41,42]. Cytosolic calcium overload
(following treatment with calcium-mobilizing agents: ionomycin,
A23187 or thapsigargin (TG)) has been also connected to apoptosis
through the activation of Ca2+-activated protein phosphatase calcine-
urin. Calcineurin dephosphorylates BCL-2-associated agonist of cell
death (BAD), a pro-apoptotic member of the BCL-2 family, thus enhanc-
ing BAD heterodimerizationwith BCL-XL and promoting apoptosis [43].
Alternatively, ER-stress induction following alterations in ER-
calcium homeostasis can activate speciﬁc ER-localized caspase-12 and
thus can trigger apoptosis in a mitochondria-independent manner [44,
45]. In addition, calcium-dependent cleavage and activation of
caspase-12 by m-calpain has been suggested as a mechanism underly-
ing apoptotic cell death induced by oxygen and glucose deprivation
[46]. Increase in cytosolic calciumhas been also connected to the activa-
tion of several DNA-degrading endonucleases [47].
Mitochondrial, ER and cytosolic calcium levels are regulated by cal-
ciumpermeable ion channels localized either on themembranes of spe-
ciﬁc intracellular organelles or on the plasma membrane [48,49]. Thesecalcium permeable channels are highly heterogenous and include fam-
ilies of transient receptor potential (TRP) channels, store-operated
channels (SOCs), voltage-gated calcium channels, as well as mitochon-
drial calcium uniporter (MCU), voltage-dependent anion channels
(VDACs), IP3 and ryanodine receptors, and others. These channels con-
tribute to changes in [Ca2+]i by providing Ca2+ entry pathways, by
modulating the driving force for the Ca2+ entry, and also by providing
intracellular pathways for Ca2+ uptake/release into/from cellular or-
ganelles [48–51]. Thus, modulation of calcium-permeable ion channel's
expression/function affects intracellular Ca2+ concentrations and con-
sequently calcium-dependent processes, including apoptosis [10].
Inositol 1,4,5-trisphosphate receptor. The ER is the major Ca2+
store in most cells. The inositol 1,4,5-trisphosphate receptor (IP3R) rep-
resents primary calcium release channel on ER membranes. Under nor-
mal conditions this channel is responsible for Ca2+ release into the
cytoplasm, in response to inositol 1,4,5-trisphosphate (InsP3) genera-
tion stimulated by numerous stimuli, to maintain normal calcium ho-
meostasis [52,53]. Apoptotic stimuli often provoke increased calcium
release through IP3R, which in turn causes augmented mitochondrial
calcium uptake and apoptosis induction [53]. In line with this silencing
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cytes in response to different stimuli [54–56]. Several mechanisms un-
derlying a pro-apoptotic role of IP3R have been proposed. First, is
direct transfer of calcium fromER tomitochondria through IP3R [57]. In-
deed, it is well established that ER and mitochondria form contacts,
called mitochondria-associated membranes (MAMs), which are crucial
for lipid and calcium exchange between these organelles [58]. IP3R has
been shown to localize to MAMs and mediate the calcium transfer
from ER to mitochondria to support bioenergetics [59–61]. Stimulation
of increased ER calcium release through IP3R by apoptotic stimuli will
enhance calciumuptake bynearbymitochondria,whichmay trigger ap-
optosis through opening of MPTP [40]. Second, is cleavage of IP3R by
caspase-3 or calpains, which has been suggested to provide an en-
hanced ER calcium leak pathway promoting cell death [62–65]. Third,
is direct binding of Cyt C to IP3R, which ampliﬁes calcium-dependent
apoptosis. It has been demonstrated, that in HeLa and PC12 cells treated
with staurosporine Cyt C directly binds to IP3R early in apoptosis and
blocks Ca2+-dependent inhibition of channel function, thus prolonging
cytosolic Ca2+ oscillations and promoting further Cyt C release in a feed-
forward loop [66]. Othermechanisms underlying a pro-apoptotic role of
IP3R include interaction with different members of BCL-2-family [67],
phosphorylation by PKB/Akt, which leads to the suppression of “deadly”
IP3R activity and thus protects from apoptosis [68], pro-apoptotic regu-
lation by phosphatase and tensin homolog deleted on chromosome 10
(PTEN) [69], pro-apoptotic modulation by the tumor suppressor
promyelocytic leukemia protein (PML) [70], and others [67]. In cancer,
current evidence suggests the importance of IP3R in control of tumor
growth, resistance to chemotherapy and aggressiveness. Thus, the
anti-apoptotic role for IP3R type III has been proposed in colorectal car-
cinoma, where knockdown of this receptor enhanced apoptosis, where-
as high levels of IP3R type III have been associated with increased
aggressiveness [71]. The increased levels of IP3R type III have been
also found in glioblastoma cells [72]. In contrast, markedly reduced ex-
pression of IP3R type I in cisplatin-resistant bladder cancer cells com-
pared to parental cells has been demonstrated. Further, knockdown of
IP3R type I in these cells prevented cisplatin-induced apoptosis [73]. It
seems that the contribution of IP3R to cancer-related processes could
vary depending on cancer type, IP3 isoform involved, expression levels
as well as regulation by proto-oncogenes and tumor suppressors [67].
Ryanodine receptor. The role of another major ER Ca2+-release
channel, ryanodine receptor (RyR), in the regulation of apoptosis is
much less studied compared to IP3R. It has been demonstrated, that
RyR type II is involved in Ca2+-transfer from sarcoplasmic reticulum
(SR) to mitochondria in the heart through direct coupling of mitochon-
drial voltage-dependent anion channel 2 (VDAC2)with RyR type II [74].
Hence, apparently RyR could regulate apoptosis via similar to IP3R path-
ways including opening of MPTP (following increased mitochondrial
calcium uptake), activation of calcium-dependent effectors involved
in the control of apoptosis (i.e. calpains) and others [75,76]. The in-
volvement of RyR in TNFα-induced apoptosis in hepatoma cells has
been also suggested [77]. Activity of both IP3R and RyR has been
shown to regulate the susceptibility of β-cells to ER stress resulting
from impaired sarco/endoplasmic reticulum ATPase (SERCA) function
[78]. Consistent with this, inhibition of ER Ca2+-release through RyR
and IP3R has been demonstrated to protect cortical neurons against
NMDA-induced excitotoxicity by reducing cytosolic Ca2+ increase and
attenuating both mitochondrial damage and ER stress [79]. Recently,
an anti-apoptotic BCL-2 protein has been identiﬁed as a new inhibitor
of RyR suggesting an important regulatory mechanism, by which RyR
activity controls cell fate [80].
Mitochondrial Calcium Uniporter. As it was stated above, the ex-
cessive mitochondrial calcium uptake can lead to the opening of MPTP
resulting in triggering of intrinsic apoptotic pathway. Mitochondrial
Calcium Uniporter (MCU) represents the calcium-permeable channel
of the inner mitochondrial membrane responsible for Ca2+ uptake
into thematrix and thus plays a crucial role in the control ofmetabolismand apoptosis [81,82]. Recent data have shown that microRNA miR-25
decreases mitochondrial Ca2+ uptake through selective MCU downreg-
ulation and in this way protects cells from Ca2+-dependent apoptosis.
MCUappears to be downregulated in human colon and prostate cancers
and this correlates well with upregulation of miR-25 [83]. Expression of
anti-miR-25 in PC3 prostate cancer cells or in HCT116 colon cancer cells
increasedmitochondrial Ca2+ levels and re-sensitized cells to apoptosis,
conﬁrming the key role of mitochondrial Ca2+ accumulation in the
mitochondria-dependent apoptotic pathways [83]. In contrast, elevated
levels of MCU have been detected in estrogen receptor negative and
basal-like breast cancers [84]. Interestingly, MCU silencing did not
alter caspase-dependent cell death initiated by BCL-2 inhibitor ABT-
263, while ionomycin-induced caspase-independent cell death was po-
tentiated by MCU knockdown independently of changes in cytosolic
Ca2+ levels. Thus, the authors concluded that MCU overexpression
may offer a survival advantage against some cell death pathways and in-
hibition of MCU was proposed as a therapeutic strategy to treat breast
cancers [84]. Recently, the physiological role of mitochondrial calcium
has been revealed by mice lacking the MCU [85]. Importantly, mito-
chondria from MCU(−/−) mice lacked evidence for calcium-induced
MPTP opening. However, the lack of MPTP opening does not protect
them against a wide range of apoptotic stimuli, indicating that, at least
in some cell types, the uptake of calcium by mitochondria is not essen-
tial for apoptosis [85,86]. As for MPTP, several recent studies suggested
that ATP synthase has a central role inmitochondrial permeability tran-
sition. Both ATP synthase dimmers as well as c-subunit of ATP synthase
have been proposed to be the pore-forming units of MPTP [87–89]. De-
pletion of the c-subunit has been reported to inhibit Ca2+- and H2O2-
induced cell death to a similar extent to that of MPTP inhibitor cyclo-
sporine Awhereas increasing the expression of the c-subunit sensitized
cells to death [87].
Voltage-dependent anion channel. LikeMCU transfers Ca2+ across
the innermitochondrialmembrane, the voltage-dependent anion chan-
nel (VDAC) imports Ca2+ across outer mitochondrial membrane
(OMM). VDAC represents the most abundant protein of the OMM and
its physiological function consists in transporting of ions, adenine nucle-
otides, NADH, and other metabolites between the cytoplasm and mito-
chondria [90]. VDAC has been proposed to mediate mitochondria-
dependent cell death through the formation of MPTP [91], however
this idea was challenged by other scientists [92]. Nevertheless, a num-
ber of studies strongly suggest that VDAC is critically involved in the
regulation of cell fate through the interactions with numerous proteins
including members of BCL-2 family, cytoskeletal elements, chaperones
and others [57,93]. The ﬁnal contribution of VDAC to cell death/survival
has been also reported to be isoform- and stimulus-dependent. For ex-
ample, VDAC1 is considered to be a pro-apoptotic protein [94], whereas
VDAC2 has shown anti-apoptotic functions [95]. Interestingly, VDAChas
been shown to have a higher permeability to Ca2+ in the closed state
(associated with lower permeability to metabolites, disruption of mito-
chondrial homeostasis and apoptosis induction) than that in the open
state [96,97]. Recombinant expression of VDAC has been reported to en-
hance the transfer of Ca2+ to mitochondria and increase the ceramide-
induced cell death inHeLa cells [98]. Moreover, VDAC1was shown to be
physically linked to the IP3R on ER through the molecular chaperone
glucose-regulated protein 75 (GRP75), thus providing a direct pathway
for Ca2+ transfer from ER to mitochondria [99]. In contrast, VDAC2 and
VDAC3 isoforms do not form complexes with IP3R, suggesting that anti-
apoptotic role of VDAC2 does not involve the transmission of Ca2+ sig-
nals [100]. Thus, VDAC1 has been suggested to selectively transfer apo-
ptotic Ca2+ signals to mitochondria [100].
Store-operated calcium channels. The store-operated calcium
channels (SOCs) represent one of the major calcium-entry pathways
in non-excitable cells. SOCs are plasmamembrane ion channels activat-
ed in response to ER Ca2+ store depletion and thereby provide Ca2+ for
ER store reﬁlling as well as for signalling purposes [101]. Themajormo-
lecular components of SOC are stromal interaction molecule 1 (STIM)
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um channel and STIM1 represents an ER-localized protein, functioning
as a sensor of ER calcium. Following ER Ca2+ depletion STIM1 translo-
cates to the plasma membrane, where it interacts with and activates
ORAI1 channel, thereby mediating store-operated calcium entry
(SOCE) [102,103]. SOCs and in particular their major components
ORAI1 and STIM1 have been shown to be implicated in a number of
physiological and pathological processes including apoptosis [104,
105]. However, the role of SOCs in apoptosis seems to be dependent
on multiple factors such as cell type, apoptotic stimuli as well as intra-
cellular signaling pathway involved. Thus, several studies suggest that
SOCE, ORAI1 as well as STIM1 contribute to apoptosis induced by vari-
ous stress stimuli [106,107], whereas others demonstrate their pro-
survival antiapoptotic role [108–111]. Indeed, ORAI1 has been demon-
strated to contribute to the establishment of an apoptosis-resistant phe-
notype in prostate cancer cells and ORAI1 knockdown protected LNCaP
cells against TG- or oxaliplatin/cisplatin-induced apoptosis [106]. The
authors proposed that ORAI1 constitutes the principal source of Ca2+
inﬂuxused byprostate cancer cells to trigger apoptosis viamitochondri-
al and cytosolic mechanisms [106]. Consistent with this, pharmacologi-
cal SOCE inhibition or STIM1 knockdown have been shown to inhibit
hydrogen peroxide-induced apoptosis in HT22 cells via alleviation of in-
tracellular Ca2+ overload, restoration of the mitochondrial membrane
potential and decrease of cytochrome C release [112]. In contrast, phar-
macological inhibition of SOCE or downregulation of STIM1 have been
shown to enhance apoptosis induced by cisplatin in non-small cell
lung cancer cells [110]. Similar results were obtained on ovary carcino-
ma cells, where cisplatin-induced apoptosis was signiﬁcantly lower in
cisplatin-resistant cells (characterized by the increased expression of
both ORAI1 and STIM1) than in parental cells. Pharmacological SOC in-
hibition by 2-APB or Akt inhibition by SH-6 restored cisplatin sensitivity
of resistant cells. The authors concluded, that ORAI1/STIM1 play protec-
tive anti-apoptotic role in these cells and proposed that enhanced Akt
activity could be responsible for this [113]. Recently, we have demon-
strated that ORAI1 and STIM1 play pro-survival antiapoptotic role in
pancreatic adenocarcinoma cell lines, as siRNA mediated knockdown
of ORAI1 and/or STIM1 increased apoptosis induced by chemotherapy
drugs 5-ﬂuorouracil (5-FU) or gemcitabine [109]. Further, it was report-
ed that Orai1-driven Ca2+-entry delays the induction of the CD95-
mediated apoptotic signal in leukemic T-cell lines through the translo-
cation of the Ca2+-dependent protein kinase C (PKC) β2 to the DISC
and its subsequent inactivation in T-cells. This prevented CD95-
mediated caspase activation anddelayed delivery of the apoptotic signal
[108]. When analyzing the involvement of SOCs in apoptosis regulation
in different cell models, one should take inmind that ORAI protein fam-
ily comprises three members ORAI1, ORAI2 and ORAI3, whereas STIM
family is represented by two isoforms STIM1 and STIM2. All of these
proteins participate in SOCE in different ways as well as have SOCE-
independent functions [114,115]. Therefore, future research is indis-
pensable to better understand the speciﬁc mechanisms of apoptosis
regulation by SOCE to ﬁnally conclude if their modulators could be ef-
fective in cancer treatment in each particular case.
Transient receptor potential channels. Transient receptor potential
channels (TRP) channels are a large superfamily of 28 mammalian cat-
ion channels with diverse physiological functions and cellular distribu-
tions [51]. This superfamily is divided into six subfamilies (TRPC
(canonical), TRPM (melastatin), TRPV (vanilloid), TRPA (ankyrin-like),
TRPP (polycystin), TRPML (mucolipin)) based on structural homology.
Most of TRPs are non-selective Ca2+-permeable cation channels, with
the exception of TRPM4 and TRPM5, which are not permeable for
Ca2+. Themembers of TRP family are activated by a plethora of different
stimuli (including temperature changes, mechanical force, extra- and
intracellularmessengers, osmotic stress andmany others) and function
as important regulators of various cellular processes [51]. Consequently,
defects in expression/function of these channels have been linked to
human diseases [116]. Current evidence supports that TRP channelsare implicated in the regulation of cellular processes altered in cancer,
including proliferation, differentiation, migration and apoptosis [117].
Hereafter we discuss the involvement of some TRPs in the regulation
of apoptosis.
TRPM2, a widely expressed ion channel-enzyme, contains an enzy-
matic region with ADP-ribose (ADPR)-hydrolase activity [118]. It has
been proposed that themain physiological role of TRPM2 is to control cy-
tokine release in human monocytes [119]. TRPM2 knockdown in rat
insulinoma RIN-5 F cells has been demonstrated to signiﬁcantly suppress
Ca2+ inﬂux and cell death induced by H2O2 and TNFα, whereas the het-
erologous overexpression of this channel enhanced H2O2-induced apo-
ptosis [120]. In malignant melanoma and prostate cancer TRPM2
function has been shown to be downregulated due to the upregulation
of antisense TRPM2 transcripts. Functional knockdown of these antisense
transcripts or over-expression of wild-type TRPM2 increases melanoma
and prostate cancer cells susceptibility to apoptosis [121,122].
TRPM7, another ubiquitously expressed Ca2+-permeable nonselec-
tive cation channel with enzyme activity, contains an atypical serine/
threonine protein kinase within the C-terminal domain [123]. It is in-
volved in the regulation of cellular magnesium homeostasis [124]. In
rat basophilic leukemia mast cell line RBL-2H3 siRNA-mediated knock-
down of TRPM7 has been reported to signiﬁcantly increase apoptotic
cell death [125]. The crucial importance of TRPM7 for cell survival has
been suggested for mast cells [126], lymphocytes [127], gastric adeno-
carcinoma cells [128]. In contrast, TRPM7 has been shown to positively
regulate Fas-induced apoptosis in T-lymphocytes [129]. The authors
suggested that in response to Fas-signaling in the early phase of apopto-
sis, TRPM7 undergoes a caspase-mediated cleavage to generate two dis-
tinct proteins, the TRPM7 channel and the TRPM7 kinase. The cleaved
channel potentiates Fas-induced apoptosis through the maintenance
of Fas receptor internalization following receptor stimulation. Knock-
down of TRPM7 impaired the Fas receptor internalization thus mediat-
ing the reduction in their sensitivity to Fas-induced apoptosis [129].
TRPM8, a cold receptor in sensory neurons [130,131], was ﬁrst
cloned from the human prostate as prostate-speciﬁc gene upregulated
in cancer [132]. TRPM8 has been proposed to form a calcium-
permeable channel at both plasma membrane and ER membranes in
prostate cancer cells [133,134]. TRPM8 has been suggested to be re-
quired for the survival of prostate cancer cells, as pharmacological inhi-
bition by capsazepine or knockdown of TRPM8 in prostate cancer LNCaP
cells induced apoptosis [135]. However, in the same experimental con-
ditions, activation of TRPM8 by menthol also induced apoptosis in
LNCaP cells [135]. The authors concluded that the normal function of
TRPM8 is required for LNCaP cell survival, whereas menthol-induced
cell death is mediated at least in part by the sustained increase in cyto-
solic calcium [135]. In line with this, TRPM8 activation by menthol was
reported to decrease the viability of melanoma cells, presumably by
calcium-dependent mechanism [136]. Further, in human bladder can-
cer cells menthol induces cell death via TRPM8-mediatedmitochondrial
membrane depolarization [137]. Consistentwith this,menthol has been
demonstrated to induce TRPM8-mediated apoptosis in rat synoviocytes
via mitochondrial membrane depolarization and caspases activation
[138]. In contrast, knockdown of TRPM8 has been reported to enhance
epirubicin-induced apoptosis in human osteosarcoma cells [139].
Several members of the vanilloid subfamily of TRP channels have
been also implicated in the regulation of apoptosis. TRPV1was original-
ly identiﬁed in sensory neurons as a heat-activated ion channel, which
functions as a transducer of painful thermal stimuli in vivo [140]. The
tumor suppressor function has been suggested for TRPV1, as its expres-
sion inversely correlates with tumor grade and growth inmany cancers
[141–143]. Capsaicin, the TRPV1 agonist, has been reported to induce
TRPV1-dependent apoptosis in glioma cells. The authors demonstrated
that capsaicin induced TRPV1-mediated Ca2+ inﬂux, p38 mitogen-
activated protein kinase activation, phosphatidylserine exposure, mito-
chondrial permeability transition pore opening and mitochondrial
transmembrane potential dissipation as well as caspase-3 activation
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been suggested to induce apoptosis by both extrinsic Fas/CD95-
dependent and intrinsic mitochondrial pathway [144]. Recently, syn-
thetic vanilloid arvanil was proposed as therapeutics for high-grade as-
trocytoma [145]. By activating the ER-localized TRPV1 channel, which is
signiﬁcantly overexpressed in this type of cancer cells, it induces ER-
stress thereby promoting tumor cell apoptosis [145]. TRPV1-mediated
apoptotic cell death in rat cortical cultures has been reported to be de-
pendent on L-type Ca2+ channel opening, Ca2+ inﬂux, ERK phosphory-
lation, and reactive oxygen species production [146]. However, it should
be noted that capsaicin as well as other vanilloids have been shown to
affect apoptosis independently of TRPV1. For example, in human small
cell lung cancer capsaicin induces apoptosis via the TRPV6 channel
and the calpain pathway [147]. The role for TRPV6 in capsaicin-
induced apoptosis was also conﬁrmed in gastric cancer cells [148].
Also, several vanilloids have been proposed to act as mitochondrial in-
hibitors, able to activate apoptosis and/or necrosis via non-receptorme-
diated mechanisms [149].
TRPV2, another heat-activated TRPV channel, has been reported to
be overexpressed in several cancers [150,151]. In glioma cells, TRPV2
knockdown increased cell survival via ERK-dependent increase in BCL-
XL expression, Akt/PKB phosphorylation and decrease in Fas expres-
sion [152]. Accordingly, TRPV2 overexpression increased spontaneous
apoptosis and sensitised glioma cells to Fas- and chemotherapy-
induced apoptosis [152]. Further, triggering of the TRPV2 by cannabidiol
was demonstrated to sensitize glioblastoma cells to chemotherapy-
induced apoptosis [153]. Activation of TRPV2 by cannabidiol has been
also linked to apoptotic cell death in human T24 bladder cancer cells.
It has been proposed that T24 cell death occurred via apoptosis caused
by continuous inﬂux of calcium through TRPV2 [154]. In prostate can-
cer, TRPV2 has been suggested to contribute to apoptotic resistance of
androgen-independent prostate cancer cell lines, likely by augmenting
Ca2+ inﬂux into these cells [155].
TRPV6, a channel mediating intestinal calcium absorption in
duodendum, has been also found to be overexpressed in many cancers
[156,157]. In prostate cancer TRPV6 expression correlates with tumor
grade and TRPV6-mediated Ca2+ entry has been suggested to be in-
volved in apoptosis resistance of LNCaP cells [158]. An elevated expres-
sion of TRPV6 was also detected in colon carcinoma cells, where siRNA-
mediated TRPV6 knockdown inhibited proliferation and induced apo-
ptosis [159].
Themembers of TRPC subfamily also contribute to apoptosis regula-
tion. For example, TRPC6 overexpression induces calcium-dependent
apoptosis in cancer cells [160]. TRPC6-mediated calcium entry has
been demonstrated to be involved in high glucose-induced podocyte
apoptosis through the RhoA/ROCK pathway [161].
TRPC1-mediated Ca2+ inﬂux has been implicated in oxidized low-
density lipoprotein-induced apoptosis in vascular smooth muscle cells
[162]. Further, TRPC1 overexpression has been found to sensitize intes-
tinal epithelial cells to apoptosis by increasing activity of protein phos-
phatase 2A followed by the NF-kappaB inhibition [163]. In contrast,
TRPC1 was shown to protect human neuroblastoma cells against
salsolinol-induced apoptosis by inhibiting cytochrome c release and
BAX downregulation [164].
Other subfamilies of TRP family also have their representatives in ap-
optosis regulatory pathways. TRPA1 activation in small cell lung cancer
cells prevented apoptosis induced by serum starvation and thus pro-
moted cell survival, an effect which could be blocked by inhibition of
TRPA1 or ERK1/2 [165].
TRPP2, the ion channel mutated in autosomal dominant polycystic
kidney disease, has been shown to protect cells from apoptosis by low-
ering the Ca2+ concentration in the ER [166]. ER-resident TRPP2 in-
creases the ER permeability to Ca2+ and as such reduces Ca2+ release
from the ER in response to apoptotic stimuli. Knockdown of TRPP2 in
renal epithelial cells increases ER Ca2+ release and augments sensitivity
to apoptosis [166].Recently, the role of TRPML1 channels in Fas-mediated apoptosis in
coronary arterial myocytes has been demonstrated [167]. Activation of
Fas receptor by Fas ligand induced lysosomal Ca2+ release (through ly-
sosomal TRPML1) followed by calcium release from sarcoplasmic retic-
ulum and activation of calpains and calcineurin. Silencing of TRPML1
signiﬁcantly attenuated FasL-induced apoptosis and activation of
calpain and calcineurin, whereas TRPML1 overexpression enhanced
them [167].
TRPML3 channel mutated in varitint-waddler mouse has been asso-
ciated with apoptotic death of sensory hair cells [168]. The varitint-
waddler mutation A419P renders TRPML3 constitutively active,
resulting in sustained inﬂux of Ca2+ and subsequent apoptosis. The
cell death aswell as intracellular level of Ca2+was signiﬁcantly reduced
by expression of plasmamembrane calcium ATPase PMCA2 [168]. Sim-
ilar mechanism has been proposed also for TRPML2 [169].
Accumulated evidence strongly suggests the involvement TRP chan-
nels in the regulation of apoptosis. However, in many cases the precise
mechanisms of such regulation are elusive, suggesting the need in fu-
ture research in this area.
Voltage-gated calcium channels. Voltage-gated calcium channels
(VGCC) mediate Ca2+ entry into cells in response to membrane depo-
larization [170]. Based on their activation threshold, they can be divided
into two subgroups: low-voltage-activated (including L-, P/Q-, N- and
R-types) and high-voltage-activated (T-type) channels [171]. VGCC
are implicated in the regulation of various important physiological pro-
cesses including gene transcription,muscle contraction, hormone secre-
tion, and neurotransmitter release [170]. Several reports have
connectedVGCC to apoptosis regulation. Depolarization-triggered calci-
um entry through L-type calcium channels has been found to cause mi-
tochondrial disruption and apoptosis in chromafﬁn cells [172]. Thus, it
appears that L-type channels translate membrane depolarization into
an apoptotic stimulus. Further, Bcl2 has been reported to increase apo-
ptotic resistance of PC12 cells by reducing Ca2+ entry andmitochondri-
al Ca2+ overload through indirect downregulation of L-type Ca2+
channels [173]. L-type calcium channels have been also implicated in
apoptosis of pancreatic beta cells in patients with insulin-dependent di-
abetes mellitus (IDDM) [174]. Serum from patients with IDDM in-
creased L-type calcium channel activity and caused cytoplasmic Ca2+
overload, thus triggering apoptosis [174]. Similarly, low-voltage-
activated (presumably T-type) calcium channel mediated cytokine-
induced pancreatic beta-cell apoptosis through the increase in basal cy-
toplasmic free Ca2+ concentration [175]. In contrast, T-type Ca2+ chan-
nel inhibition has been reported to induce p53-dependent apoptosis
through activation of p38-MAPK in colon cancer cells [176]. In malig-
nant melanoma cells knockdown or pharmacological inhibition of T-
type channels induced ER-stress, inhibited autophagy and stimulated
caspase-dependent apoptosis [177]. In glioblastoma cells, inhibition of
T-type calcium channels disrupted Akt signaling and promoted apopto-
sis via reduction in BAD phosphorylation and caspases activation [178].
However, in spermatogenic cells inhibition of T-type channels
prevented 2,5-hexanedione-induced mitochondrial potential loss, re-
duced caspase-3 activity, and increased cell survival via increase in
anti-apoptotic BCL-XL expression and decrease in proapoptotic BCL-XS
expression [179].
Given the important role of T-type channels in the regulation of ap-
optosis as well as other cancer-related processes, these channels were
proposed as attractive molecular targets for anticancer therapy [180].
However, considering differential role of VGCC in apoptosis regulation
in different cell models, further studies are necessary to uncover speciﬁc
mechanisms of such regulation in each particular case.
3.2. Potassium and potassium channels
One of the characteristic morphological features of apoptosis is cell
shrinkage [1]. A number of studies have linked cell shrinkage to potassi-
um ions loss. Indeed, being the predominant ion inside the cell K+ ions
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Moreover, cytoplasmic K+ loss has been shown to favor activation of
caspases and nucleases, which lead to apoptosis [183,184]. Indeed, sev-
eral studies demonstrated that cellular K+ depletion by valinomycin
(K+ ionophore) or plasma membrane K+ channel overexpression in-
duces apoptosis in different cell types [185–187]. Further, high extracel-
lular K+ has been reported to inhibit both the extrinsic and the intrinsic
apoptosis, presumably by inhibiting the Cyt C release [188].
Potassium channels represent transmembrane proteins mediating
the ﬂow of potassium ions down their electrochemical gradient. K+
channels are widely distributed in a vast variety of cells (both excitable
and non-excitable) and are involved in a plethora of physiological pro-
cesses including maintenance of membrane potential, cell proliferation
and apoptosis [189,190]. Based on structural criteria, conductance
properties as well as activation mechanisms potassium channels are di-
vided into four classes: voltage-gated, calcium-activated, inward-
rectiﬁer and two-pore-domain potassium channels [189]. Various
members of these four classes have been implicated in apoptosis regu-
lation. For the complete list of potassium channels involved in the regu-
lation of apoptosis we refer the reader to the comprehensive reviews on
this subject [190–194]. Here we provide a brief overview of this area of
research.
Given that K+ efﬂux has been proposed to be a pro-apoptotic factor,
plasma membrane potassium channels mediating K+ efﬂux out of the
cell represent good candidates for apoptosis regulation. However, con-
sidering uneven distribution of K+ channels among different cell
types, the speciﬁc channel that is involved varies, depending on apopto-
tic stimulus and cell type. For example, Kv2.1 channels have been
shown to be responsible for oxidant and staurosporine-induced apopto-
sis in neurons [195]. In contrast, in glioblastoma cells intermediate-
conductance calcium-activated potassium (IK) channel is implicated
in the staurosporine-activated intrinsic apoptotic pathway while
large-conductance calcium-activated potassium (BK) channels were re-
ported to be responsible for extrinsic apoptosis [196]. In neurons,
syntaxin-dependent incorporation of Kv2.1 voltage-gated potassium
channels into the plasma membrane has been shown to mediate K+
current increase during apoptosis. Both p38 MAPK and Ca2+/
calmodulin-dependent protein kinase II (CaMKII) have been implicated
in this process [197,198].
In vascular smoothmuscle cells, disruption ofmitochondrial homeo-
stasis by carbonyl cyanide-p-triﬂuoromethoxyphenyl-hydrazone
(FCCP) induced apoptosis which was connected to an increase in BK
channel activity [185]. Moreover, activation of BKCa channels has been
implicated in TNFα- and nitric oxide-induced apoptosis [199,200].
HERG conductance has been demonstrated to promote hydrogen
peroxide-induced apoptosis of various tumor cells [201].
Members of two-pore-domain potassium channels have been also
reported to contribute to apoptotic cell death [202]. For example,
TWIK-related acid-sensitive potassium channel 3 (TASK3) has been
shown to contribute to TNFα-induced apoptosis in a JNK- and p38-
dependentway [203]. Both TASK1 and TASK3have been also implicated
in K+-dependent apoptosis of cerebellar granule neurons [204]. Fur-
thermore, hydrogen peroxide-mediated apoptosis was associated with
activation of TREK channels [205].
Activation of K+ channels by Cyt C has been proposed to play an im-
portant role in initiating the apoptotic volume decrease when cells un-
dergo apoptosis [206]. Overexpression of BCL-2 accelerated the
inactivation and downregulated the mRNA of Kv1.1, Kv1.5, and Kv2.1
channels in vascular smooth muscle cells, thus representing an addi-
tional mechanism involved in the BCL-2-mediated anti-apoptotic effect
[207].
A set of K+ channels has been found to be localized onmitochondrial
membranes [208]. These channels include inward rectifying channel
(Kir), ATP-dependent potassium channel (KATP), BKCa, IKCa, Kv1.3
and TASK3 [209]. Mitochondrial potassium channels regulate mito-
chondrial volume, mitochondrial ROS production and ATP synthesis[209]. Thus, alterations in these channels could lead to the disturbance
in mitochondrial homeostasis and subsequently to apoptosis. Indeed,
mitochondrial potassium channels have been implicated in apoptosis
regulation in variety of cell types. For example, mitochondrial potassi-
um channel Kv1.3 has been suggested tomediate BAX-induced apopto-
sis in lymphocytes [210]. BAX has been shown to interact with and
inhibitmitochondrial Kv1.3, that triggered hyperpolarization, formation
of reactive oxygen species, release of Cyt C and apoptosis [210]. Similar
mechanism was proposed to be shared by other mitochondrial Kvs,
namely Kv1.1 and Kv1.5 [211]. Moreover, pharmacological inhibitors
of mitochondrial Kv1.3 were recently reported to induce cancer cell ap-
optosis independently of BAX and BAK expression. More speciﬁcally,
Psora-4, PAP-1 or clofazimine (membrane-permeant Kv1.3 inhibitors)
efﬁciently induced apoptosis in Bax/Bak-double deﬁcient human Jurkat
leukemic T cells as well as in Bax/Bak-double knock-outmurine embry-
onic ﬁbroblasts [212,213].
Recently, despite the widely appreciated role of K+ efﬂux in apo-
ptosis, it was proposed that intracellular K+ concentration decrease
is not obligatory for apoptosis [214]. The authors showed that in
Xenopus oocytes caspase-3 activity is not dependent on the intracel-
lular concentration of K+ and suggested that there is no causal link
between the K+ reduction and the caspase-dependent apoptotic
process [214].
Considering their role in apoptosis regulation, potassium chan-
nels have gained much of attention as potential regulators of cancer
cell death and promising anticancer therapeutic targets. Aberrant
expression of potassium channels is frequently observed in different
cancers [192]. However, some cancers are characterized by increased
expression of some potassium channels, while others show down-
regulation, suggesting cell-type-speciﬁc functions of these channels
[215–217]. Thus, it seems that the contribution of potassium chan-
nels to the regulation of apoptosis in cancer could vary depending
on cancer type, potassium channel type, expression levels, intracel-
lular localization as well as regulation by pro- or anti-apoptotic
factors.
3.3. Sodium and sodium channels
AlongwithK+ ionswhichhave been proposed to be critical determi-
nants of cell volume and apoptosis, other monovalent ions, including
Na+ and Cl−, have been also demonstrated to play the role in apoptosis.
Accumulated data suggest that an increase in intracellular Na+ occurs
early in apoptosis [218,219]. Moreover, several studies also reported a
late increase in cytoplasmic Na+ in apoptotic cells [220,221]. Interest-
ingly, in the absence of physiological levels of extracellular sodium apo-
ptotic stimulation resulted in Jurkat T-cell swelling and not cell
shrinkage, suggesting that sodium controls cell morphology during ap-
optosis [222]. However, despite swelling these cells showed all the
other characteristic features of apoptosis, such as caspase activity,
DNA fragmentation and phosphatidylserine externalization [222].
Sodium inﬂux has been suggested to contribute to plasma mem-
brane depolarization frequently observed early in apoptosis [223,224].
However, sodium was not involved in anti-Fas induced depolarization,
while mediating depolarization early in of arsenic trioxide-induced ap-
optosis inmyeloid cells. Thus, the existence of different mechanisms for
apoptotic plasma membrane depolarization within one cell type has
been suggested [224].
Sodium has been also implicated in early phosphatidylserine expo-
sure triggered by purinoreceptor P2X7 activation in thymocytes [225].
Moreover, it has been proposed that intracellular sodium may control
K+ efﬂux during apoptosis via stimulation of muscarinic K+ channel
(KACh) [226] as well as G protein-gated K+ channels (GIRK, or Kir3)
[227].
Sodium channels represent the integralmembrane proteinsmediat-
ing the inﬂux of Na+ ions into the cell. According to the mechanism of
activation sodium channels could be classiﬁed into voltage-gated
2539A. Kondratskyi et al. / Biochimica et Biophysica Acta 1848 (2015) 2532–2546sodium channels (VGSC) and voltage-independent sodium channels
comprising epithelial sodium channels (ENaCs), acid-sensing sodium
channels (ASICs) and sodium leak channel NALCN [228–231]. However,
despite understanding of the important role Na+ ions play in apoptosis,
the data on the involvement of sodium channels in apoptosis regulation
are rather scarce.
Activation of voltage-sensitive sodium channels during oxygen dep-
rivation has been demonstrated to lead to apoptotic caspase-3-
dependent neuronal death, whereas inhibition of sodium channels by
tetrodotoxin (TTX) attenuated caspase-3 activation and apoptosis
[232]. The sodium channelmodulator veratridine has been shown to in-
duce neuronal apoptosis, which could be prevented by TTX. The report-
ed mechanism involves Ca2+, mitochondria, reactive oxygen species
and p53 activation [233]. In line with this, AM-36, a neuroprotective
agent incorporating both antioxidant and sodium channel blocking ac-
tions, completely inhibited veratridine-induced neuronal toxicity
[234]. Saxitoxin, a sodium channel blocker, has been shown to prevent
anti-Fas induced apoptosis in Jurkat T-cells by preventing sodium inﬂux
[222].
Interestingly, the expression/function of the shrinkage-activated
ENaC has been reported in rat hepatocytes [235]. During cell shrinkage
this channel is activated by the cell volume-sensitive serine/threonine
kinase hSGK. This mechanism could contribute to the increase in intra-
cellular sodium during apoptosis [235].
Blockade of ASICs by amiloride has been suggested to protect articu-
lar chondrocytes from acid-induced apoptotic injury [236,237]. Howev-
er, in these studies pro-apoptotic role of ASICs has been explained by
calcium-permeability of these channels. Thus, acidosis triggers ASIC-
mediated calcium inﬂux which induces apoptosis by mitochondria- or
calpain/calcineurin-dependent pathways. Inhibition of this calcium
inﬂux by amiloride prevented acid-induced apoptosis [236,237].
Calcium-permeable ASIC1a has been also implicated in acid-induced
neuronal cell death [238,239].
Functional expression of sodium channels has been reported in dif-
ferent cancers, including those of prostate, breast, colon, lung, skin and
others [240]. Aberrant expression of some sodium channels has been
also demonstrated in several cancers [241,242]. However, pharmaco-
logical targeting of sodium channels in cancer commonly results in the
changes inmetastatic behavior of cancer cells without signiﬁcant effects
on viability. It should be noted that nonselective cation channels, for ex-
ample the members of TRP channels family, are also permeable for Na+
ions, suggesting that these channels could potentially regulate apopto-
sis by Na+-dependent mechanisms.
3.4. Chloride and chloride channels
As it was previously mentioned, cell shrinkage or apoptotic volume
decrease (AVD) represents one of the characteristic morphological fea-
tures of apoptosis. Chloride ions are inextricably linked to this phenom-
enon. Numerous studies have demonstrated that during AVD chloride
ions leave the cell similarly to potassium ions [181,243,244]. A variety
of apoptotic stimuli in different cell types have been shown to induce
activation of chloride currents. Importantly, inhibition of these currents
was found to prevent AVD and inhibit apoptotic cell death [243,245,
246].
Chloride ﬂow across the cell membranes is mediated by chloride
channels. The Cl− channels are ubiquitously expressed and participate
in many physiological processes including volume regulation, acidiﬁca-
tion of intracellular organelles, cell cycle and apoptosis [247]. According
to the gating mechanisms chloride channels could be classiﬁed into
voltage-gated chloride channels (the ClC family), cystic ﬁbrosis trans-
membrane conductance regulator (CFTR), Ca2+-activated chloride
channels (CaCCs), volume-regulated anion channels (VRACs) and li-
gand gated anion channels [247]. It should be noted that chloride chan-
nels are permeable for various anions, suggesting that other ions along
with Cl− could mediate the ﬁnal effects of channels opening. However,given that Cl− is the most abundant anion in all organisms it is widely
accepted that Cl− constitutes the predominant ion passing through
chloride channels [248].
The most studied Cl− channels for their role in AVD and apoptosis
are volume-regulated anion channels (VRACs). VRACs have been impli-
cated in regulatory volume decrease (RVD) in response to hypoosmotic
stress-induced cell swelling [249]. Cell swelling activates VRACs, which
mediate Cl− efﬂux (accompanied byK+ efﬂux through potassiumchan-
nels) resulting in osmotic-driven H20 efﬂux and cell volume restoration.
Given that AVD is accompanied by Cl− ions loss, it is not surprising that
VRACs have been implicated in apoptotic pathway. Thus, VRACs activa-
tion (alternatively named volume-sensitive outwardly rectifying
(VSOR) chloride channels) have been observed in a wide variety of
cell types in response to a number of apoptotic stimuli [245]. For exam-
ple, it has been demonstrated that both mitochondria- and death
receptor-mediated apoptosis inducers (staurosporine and Fas ligand
or TNFα) activate chloride currents in human epithelial HeLa cells
[250]. These currents exhibited the properties characteristic of VSOR
currents, including outward rectiﬁcation, inhibition by cell shrinkage,
sensitivity to chloride channel blockers, and dependence on cytosolic
ATP [250]. Thus, it appears that during AVD VSORs are highly sensitized
and could be activated even in non-swollen cells. Several mechanisms
have been proposed to explain this increased sensitivity of VSORs, in-
cluding modulation by ROS [250] and cytosolic ATP [251].
Importantly, pharmacological inhibition of VSORs by DIDS, SITS,
NPPB or phloretin prevented staurosporine-, TNFα-, or Fas ligand-
induced AVD in various cell types [243,252]. Inhibition of apoptotic
cell death by VSOR blockers has been also reported [245]. However sev-
eral reports demonstrated that VSOR blockers could prevent AVDwith-
out inhibiting apoptotic cell death. For example, induction of apoptosis
by nitric oxide in macrophages was reported to be independent of
AVD and was not prevented by VSOR channel blockers phloretin and
SITS [253]. In line with this, staurosporine-, C2-ceramide-, or serum
deprivation-induced AVD was completely prevented by DIDS, SITS, or
NPPB Cl− channel blockers in cortical neurons, whereas apoptotic cell
death induced by these stimuli was only mildly attenuated [244]. The
authors attributed observed effects to ClC-2 and ClC-3 chloride chan-
nels, found to be expressed in cortical neurons. On the other hand, K+
channel blockers tetraethylammonium (TEA) or cloﬁlium completely
prevented both AVD and apoptotic cell death [244].
Moreover, inhibitory effect of Cl− channel blockers on both AVD and
apoptosis was also demonstrated in cancer. In human epidermoid can-
cer cells, Cl− channel blockers SITS and DIDS reduced cisplatin-induced
apoptotic death [254]. Conversely, VSOR activity restoration resulted in
increased apoptotic cell death following cisplatin treatment [255]. Ac-
cordingly, dysfunction of VRACs has been reported to contribute to cis-
platin resistance in human lung adenocarcinoma cells [256].
Despite the fact, that VRACs have been found to be ubiquitously
expressed and are implicated in various physiological processes, the
molecular identity of VRACs is not clear. The ClC-3 protein has been pro-
posed as one of the molecular candidates for the role of VRAC [257]. In
HeLa cells and Xenopus laevis oocytes knockdown of ClC-3 signiﬁcantly
reduced the density of cell swelling-induced VRAC current as well as
impaired the ability of cells to regulate their volume [258]. In prostate
cancer LNCaP cells ClC-3-speciﬁc antibody suppressed swelling-
activated Cl− current [259]. Unexpectedly, overexpression of BCL-2 in
these cells resulted in an increase in swelling-activated Cl− current
and an enhancement of endogenous expression of ClC-3 protein. The
authors suggested that increase in ClC-3 expression would strengthen
the ability of the cells to handle proliferative volume increases and
thereby promote their survival and diminish their proapoptotic poten-
tial [259]. This hypothesis was further strengthened by the ﬁnding,
that apoptosis-resistant neuroendocrine (NE) differentiated LNCaP
cells were characterized by the enhanced expression of ClC-3 as well
as augmented swelling-activated Cl− current [260]. Consistent with
this, overexpression of ClC-3 inhibited TGF-beta1-induced in human
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lines (BON, LCC-18, and QGP-1) ClC-3 expression has been reported to
enhance etoposide resistance by increasing acidiﬁcation of the late
endocytic compartment [262]. Indeed, as it was shown earlier, ClC-3
represents intracellular chloride channel,mainly residing on endosomal
compartments [263].
However, no signiﬁcant difference in swelling-activated currents
(recorded in mouse hepatocytes and pancreatic acinar cells) has been
observed between wild-type and ClC-3-KO mice, indicating that ClC-3
does not underlie VRAC [263]. Consistentwith this, several other studies
conﬁrmed that functional expression of VRAC in the plasmamembrane
is independent of the molecular expression of ClC-3 in different cell
types [264,265].
Several other chloride channels have been also implicated in apopto-
sis regulation. Anoctamin 6 (ANO6, or TMEM16F), a calcium-activated
anion channel, has been reported to be an essential component of the
outwardly rectifying chloride channel activated during apoptosis
[266]. However, it has been shown that ANO6 activity is not related to
VSOR [267]. Nevertheless, in a recent study it has been demonstrated
that ANO6 differs from VRAC but supports volume regulation in the
presence of Ca2+ [268]. Moreover, ANO6 is involved in cisplatin-
induced apoptosis in Ehrlich–Lettre ascites (ELA) cells, as knockdown
of ANO6 in ELA cells resulted in a decrease in cisplatin-induced
caspase-3 activity, suggestingproapoptotic role for ANO6 [268]. Further,
ANO6 has been suggested as an essential component for the Ca2+-
dependent exposure of phosphatidylserine on the cell surface, indicat-
ing another mechanism for ANO6 to regulate apoptosis [269].
Cystic ﬁbrosis transmembrane conductance regulator (CFTR), loss of
function mutations of which cause the autosomal recessive lethal dis-
ease cystic ﬁbrosis, represents a cAMP-dependent chloride channel.
Alongwith chloride channel function CFTR has been shown tomodulate
other ion channels and transporters [248]. CFTR was reported to con-
tribute to cisplatin-induced apoptosis renal proximal cells, as blockade
of CFTR by the speciﬁc inhibitor CFTRinh-172 prevented cisplatin-
induced increase of ROS, decrease of intracellular GSH content and acti-
vation of caspase-3 [270]. In Chinese hamster lung ﬁbroblasts CFTR has
been demonstrated to enhance apoptosis, probably due to the modula-
tion of the Cl−/HCO−3 exchanger, resulting in a more efﬁcient intracel-
lular acidiﬁcation [271]. Interestingly CFTR augmented chloride current
produced by pro-apoptotic Ano6 in airway epithelial cells, suggesting its
pro-apoptotic function [266].
mtCLIC/CLIC4 is an intracellular chloride channel associatedwith the
inner mitochondrial membrane, ER membrane, nucleus and cytoplasm.
CLIC4 is regulated by p53 and TNFα [272]. DNA damage or overexpres-
sion of p53 have been reported to upregulate CLIC4 and induce apopto-
sis. Overexpression of CLIC4 was demonstrated to induce apoptosis via
caspase-dependent mitochondrial apoptotic pathway. Conversely,
decrease in CLIC4 expression reduced p53-induced apoptosis [272]. Fur-
ther, multiple stress inducers were found to cause the translocation of
cytoplasmic CLIC4 to the nucleus, thereby accelerating apoptosis [273].
In line with this, CLIC4 expression is reduced in mouse and human
skin cancer cell lines and the protein is excluded from the nucleus,
thus contributing to TGF-β resistance and enhancing tumor develop-
ment [274].
4. Conclusions
It has long been known that apoptosis plays a crucial role in physiol-
ogy. Thus, apoptotic machinery has been studied in great detail and in-
cludes a variety of molecular players. Cytoplasmic and extracellular ion
concentrations as well as ion channels, mediating ion ﬂuxes across cel-
lular membranes, have emerged as important regulators of apoptosis
(Fig. 1).
Accumulated data proves that both ion channels and apoptosis dys-
functions are implicated in cancer initiation and progression as well as
chemotherapy resistance. This fact explains the constantly growinginterest in understanding the interplay between ion channels and apo-
ptosis in cancer.
Current evidence suggests the altered expression of various ion
channels in cancer. This has been linked to a number of cancer-related
processes, including apoptosis. Thus, ion channels have been proposed
as promising therapeutic targets for repairing defective apoptosis in
cancer. However, despite the essential progress achieved in this ﬁeld,
the practical utility of targeting ion channels for cancer treatment re-
mains very limited.
One of the reasons is that most ion channels have broad expression
patterns and thus are not cancer-speciﬁc. Therefore, selective targeting
is vitally important to prevent toxicity to normal cells, induced by the
pharmacological impairment of channel function. Another issue is un-
availability of highly selective pharmacological modulators for most
ion channels. The existence of alternatively spliced variants of many
channels further complicates the situation. Thus, novel selective phar-
macological agents, drug delivery techniques as well as siRNA transfec-
tion technologies are clearly needed to ﬁnally see the clinical
implications of ion channels targeting in cancer therapy.
Further, most ion channels that have a role in apoptosis have been
also implicated in other cancer-related processes, such as proliferation,
differentiation and migration. This fact should be considered when
targeting apoptosis through ion channels in cancer treatment.
One of the major obstacles preventing the announcement of ion
channel targeting as a general approach to treat cancer is differential
and paradoxical contribution of speciﬁc ion channels to apoptosis de-
pending on cancer type, ion channel type, expression levels and intra-
cellular localization, as well as regulation by pro- or anti-apoptotic
factors.
Indeed, given that Cl− ions loss is an important pro-apoptotic factor,
one could expect the downregulation or inhibition of VRACs in cancer
cells to prevent apoptosis. However, ClC-3 has been found to be
overexpressed in apoptosis-resistant prostate cancer cells and to en-
hance etoposide-resistance in neuroendocrine tumor cell lines. On the
other hand, VRACs positively contribute to cisplatin-induced apoptosis
in epidermoid cancer cells as well as human lung adenocarcinoma cells.
Further, while it's generally accepted that cytosolic and mitochon-
drial Ca2+ overload represents a strong apoptotic stimulus, it is logical
to assume that cancer cells will downregulate Ca2+-permeable chan-
nels to reduce Ca2+ inﬂux. While this is the case for some channels
such as TRPM2 and TRPV1, a number of Ca2+-permeable channels
have been demonstrated to be overexpressed in cancer, including
TRPM8, TRPV2 and TRPV6.
Similarly, the downregulation of K+ channels by cancer cells would
be expected, as K+ efﬂux promotes apoptosis. However, this is not the
case for all the cancers, as elevated expression of Kv11.1, K2P1.1, K2P3.1
and other channels has been reported in several cancers.
Moreover, one given channel could play opposite roles in apoptosis
in different cancer types. For example, TRPM8 activation by menthol
was reported to decrease the viability of melanoma cells as well as
human bladder cancer cells. In contrast, TRPM8 silencing enhanced
epirubicin-induced apoptosis in human osteosarcoma cells. Further,
TRPC1 overexpression has been found to sensitize intestinal epithelial
cells to apoptosis, while protecting human neuroblastoma cells against
salsolinol-induced apoptosis. The two isoforms of IP3R have been
also demonstrated to oppositely regulate apoptosis. Thus, the anti-
apoptotic role for IP3R type III has been proposed in colorectal carcino-
ma, contrastingwith the pro-apoptotic role of IP3R type I in bladder can-
cer cells.
Taken together, the data presented here clearly demonstrate the di-
versity and particular importance of ion channels in apoptosis regula-
tion. These channels belong to different families, control the ﬂow of
different classes of ions across cell membranes, have different gating
mechanisms as well as biophysical properties, and show different local-
ization patterns. Ion channels have been implicated in virtually all deci-
sive aspects of apoptotic process, such as cell shrinkage, cytoplasmic, ER
2541A. Kondratskyi et al. / Biochimica et Biophysica Acta 1848 (2015) 2532–2546and mitochondrial calcium signaling, as well as mitochondrial depolar-
ization and integrity. Importantly, the contribution of speciﬁc ion chan-
nels to apoptosis in cancer could vary depending on multiple factors
such as cancer type and stage, ion channel type and localization, as
well as intracellular signaling pathways involved. Therefore, no general
approach can be proposed to ﬁght cancer by ion channel targeting. Each
particular cancer case requires a personal approach. Thus, we conclude
that ion channels targeting has good prospects as a potential speciﬁc
tool for personalized cancer therapy.
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